Suppr超能文献

岩藻糖苷贮积症再探讨:77例患者的回顾

Fucosidosis revisited: a review of 77 patients.

作者信息

Willems P J, Gatti R, Darby J K, Romeo G, Durand P, Dumon J E, O'Brien J S

机构信息

Department of Medical Genetics, University of Antwerp/U.I.A., Belgium.

出版信息

Am J Med Genet. 1991 Jan;38(1):111-31. doi: 10.1002/ajmg.1320380125.

Abstract

Fucosidosis is a rare, autosomal recessive, lysosomal storage disorder caused by a severe deficiency of alpha-L-fucosidase in all tissues. We have conducted a review of fucosidosis, compiling data from published reports and an international questionnaire survey. Seventy-seven patients affected with fucosidosis of which 19 had not been reported before have been identified. A major aim of the present study was to define the natural history of fucosidosis. The clinical picture of fucosidosis consists of progressive mental (95%) and motor (87%) deterioration, coarse facies (79%), growth retardation (78%), recurrent infections (78%), dysostosis multiplex (58%), angiokeratoma corporis diffusum (52%), visceromegaly (44%), and seizures (38%). Whereas the original fucosidosis patients described by Durand et al. (J. Pediatr 75:665-674, 1969) were decerebrate and died before age 5 years, most fucosidosis patients have a slower course of degeneration. Mortality before age 5 years was observed in only 7 patients (9%), whereas 36 patients (64%) reached the second decade. We did not find evidence for the existence of clinical heterogeneity with a rapidly progressive type I and a slowly progressive type II fucosidosis as suggested in the literature. Instead, there seems to exist a wide continuous clinical spectrum. At the biochemical level no heterogeneity in residual fucosidase enzyme activity or cross-reacting immunoreactive fucosidase protein was observed. At the DNA level at least 4 different mutations must be responsible for fucosidosis. These genotypic differences however do not explain the observed phenotypic differences.

摘要

岩藻糖苷贮积症是一种罕见的常染色体隐性溶酶体贮积病,由所有组织中α-L-岩藻糖苷酶严重缺乏引起。我们对岩藻糖苷贮积症进行了综述,汇编了已发表报告和国际问卷调查的数据。已确定77例岩藻糖苷贮积症患者,其中19例此前未被报道过。本研究的一个主要目的是明确岩藻糖苷贮积症的自然病史。岩藻糖苷贮积症的临床表现包括进行性智力(95%)和运动(87%)功能退化、面容粗糙(79%)、生长发育迟缓(78%)、反复感染(78%)、多发性骨发育异常(58%)、弥漫性躯体血管角质瘤(52%)、内脏肿大(44%)和癫痫发作(38%)。杜兰德等人(《儿科学杂志》75:665 - 674, 1969)最初描述的岩藻糖苷贮积症患者呈去大脑状态,5岁前死亡,而大多数岩藻糖苷贮积症患者的退化过程较为缓慢。仅7例患者(9%)在5岁前死亡,而36例患者(64%)活到了第二个十年。我们没有找到证据支持文献中所提出的存在快速进展的I型和缓慢进展的II型岩藻糖苷贮积症这种临床异质性。相反,似乎存在一个广泛连续的临床谱。在生化水平上,未观察到残余岩藻糖苷酶活性或交叉反应免疫反应性岩藻糖苷酶蛋白的异质性。在DNA水平上,至少4种不同的突变必定导致岩藻糖苷贮积症。然而,这些基因型差异并不能解释所观察到的表型差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验